Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
8 October 2026
Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.
Latest
8 October 2026
8 October 2026
6 October 2026
6 October 2026
5 October 2026
More news
28 September 2026
A workplace wellness programme using wearable health data can flag heart risk early, cut sick leave and deliver strong returns for employers.
28 September 2026
The Health Department has referred claims about NHI advertising contracts to the SIU, AGSA, and the Public Protector for review.
28 September 2026
Learn how the United Nations is addressing pandemic preparedness five years after Covid-19 and what gaps remain.
28 September 2026
South Africa's pharmaceutical policy must weigh low medicine prices against sustaining local manufacturing and supply security.
25 September 2026
SA will miss its 2030 End TB targets, new modelling finds, with weak TB testing the biggest barrier, and point-of-care tests a key fix.
25 September 2026
The single exit price for medicines will rise 2.88% from October as the industry warns rising input costs are straining medicine supply.
23 September 2026
Medical scheme contributions face renewed scrutiny as BHF challenges the CMS's 3.8% guidance for 2027. See what is driving the cost pressure.
21 September 2026
Acute pain in African hospitals affects two-thirds of patients - what the burden means for hospital groups and medical schemes.
20 September 2026
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
19 September 2026
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
18 September 2026
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn - beating its R7bn Impact target a year early.
18 September 2026
Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.
The archive
Browse every Health Matters article by month.